FDA hires top Mylan executive: report

The Food and Drug Administration (FDA) has hired a senior executive from EpiPen maker Mylan to be a senior communications adviser in the agency, CBS News reported Friday. 

Nina Devlin, who was the head of global communications at Mylan, was reportedly hired on Oct. 15 and reports to the FDA's chief of staff. 

She has expressed support for the agency's work in combatting the opioid epidemic in the U.S., according to the network. 


Devlin's hire comes roughly two months after Mylan reached a $465 million settlement with the federal government stemming from a Justice Department claim that it had overcharged the government for EpiPens.

The EpiPen is a medical device that treats dangerous allergic reactions by injecting epinephrine.

Mylan did not admit wrongdoing in the settlement.